recombinomics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Recombinomics | Elegant |
| Description | Home Founder What’s New In The News Consulting H1N1 Consulting Paradigm Shift Viral Evolution Intervention Monitoring Vaccine Screening Vaccine Developmen |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 182.50.132.53 |
| Location | Singapore |
Related Websites
| Site | Rank |
More to Explore
recombinomics.com Valuation
|
US$1,124
Last updated: 2023-05-19 22:53:52
recombinomics.com has Semrush global rank of 0. recombinomics.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. recombinomics.com receives approximately 129 unique visitors each day. Its web server is located in Singapore, with IP address 182.50.132.53. According to SiteAdvisor, recombinomics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| recombinomics.com. | A | 600 | IP: 182.50.132.53 |
| recombinomics.com. | NS | 3600 | NS Record: ns02.domaincontrol.com. |
| recombinomics.com. | NS | 3600 | NS Record: ns01.domaincontrol.com. |
| recombinomics.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
| recombinomics.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
| recombinomics.com. | TXT | 3600 | TXT Record: NETORG6427299.onmicrosoft.com |
| recombinomics.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-19 22:53:52
| Home Founder What’s New In The News Consulting H1N1 Consulting Paradigm Shift Viral Evolution Intervention Monitoring Vaccine Screening Vaccine Development Expression Profiling Drug Discovery Custom Therapies Patents Recombinomics Recombinomics is committed to the study of recombination as the driver of rapid molecular evolution and the emergence of novel infectious agents. Home | Founder | What’s New | In The News | Contact Us Webmaster: webmaster@recombinomics.com © 2011 Recombinomics. All rights |
HTTP Headers
HTTP/1.1 200 OK Content-Length: 11583 Content-Type: text/html Last-Modified: Sun, 20 Oct 2019 12:58:52 GMT Accept-Ranges: bytes ETag: "ea3da01f4687d51:0" Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET X-Powered-By-Plesk: PleskWin Date: Wed, 07 Dec 2022 08:22:00 GMT |
recombinomics.com Whois Information
Domain Name: RECOMBINOMICS.COM Registry Domain ID: 124377715_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-09-02T17:32:40Z Creation Date: 2004-07-09T04:25:25Z Registry Expiry Date: 2023-07-09T04:25:25Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-07T08:02:38Z <<< |